Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1959 2
1960 2
1963 4
1965 3
1966 6
1967 2
1968 3
1969 1
1970 1
1971 5
1973 1
1974 1
1975 3
1976 7
1977 2
1978 4
1979 1
1980 2
1981 4
1982 4
1984 6
1987 3
1989 2
1990 5
1991 4
1992 2
1993 4
1994 3
1995 1
1996 9
1997 1
1998 1
1999 4
2000 5
2001 4
2002 4
2003 12
2004 5
2005 7
2006 12
2007 8
2008 6
2009 7
2010 7
2011 12
2012 3
2013 5
2014 7
2015 9
2016 12
2017 13
2018 15
2019 17
2020 13
2021 17
2022 5
2023 13
2024 6
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Results by year

Filters applied: . Clear all
Page 1
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Coccidioidomycosis.
Parish JM, Blair JE. Parish JM, et al. Mayo Clin Proc. 2008 Mar;83(3):343-48; quiz 348-9. doi: 10.4065/83.3.343. Mayo Clin Proc. 2008. PMID: 18316002 Review.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. JAMA Dermatol. 2025 Feb 1;161(2):147-156. doi: 10.1001/jamadermatol.2024.4796. JAMA Dermatol. 2025. PMID: 39602139 Clinical Trial.
Cyber-Bullying and the Dermatologist.
Parish JL, Parish LC, Lambert WC. Parish JL, et al. Skinmed. 2019 Mar 19;17(1):8-9. eCollection 2019. Skinmed. 2019. PMID: 30888941 No abstract available.
The rash that presents as target lesions.
Wolf R, Parish JL, Parish LC. Wolf R, et al. Among authors: parish jl. Clin Dermatol. 2019 Mar-Apr;37(2):148-158. doi: 10.1016/j.clindermatol.2018.12.008. Epub 2018 Dec 5. Clin Dermatol. 2019. PMID: 30981295 Review.
Impetigo herpetiformis.
Oumeish OY, Parish JL. Oumeish OY, et al. Among authors: parish jl. Clin Dermatol. 2006 Mar-Apr;24(2):101-4. doi: 10.1016/j.clindermatol.2005.10.009. Clin Dermatol. 2006. PMID: 16487882 Review.
Modelling human papillomavirus biology in oropharyngeal keratinocytes.
Roberts S, Evans D, Mehanna H, Parish JL. Roberts S, et al. Among authors: parish jl. Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180289. doi: 10.1098/rstb.2018.0289. Philos Trans R Soc Lond B Biol Sci. 2019. PMID: 30955493 Free PMC article. Review.
The Conundrum of Toys and Hobbies: Nitendo.
Wolf R, Parish JL, Parish LC. Wolf R, et al. Among authors: parish jl. Skinmed. 2021 Jun 1;19(3):175-176. eCollection 2021. Skinmed. 2021. PMID: 34303385 No abstract available.
317 results